right-img

Home | Peregrine Pharmaceuticals (PPHM) Issues Earnings Results, Misses Estimates By $0.01 EPS

Peregrine Pharmaceuticals (PPHM) Issues Earnings Results, Misses Estimates By $0.01 EPS

March 14, 2017
Peregrine Pharmaceuticals (NASDAQ:PPHM) released its earnings results on Monday. The biopharmaceutical company reported ($0.04) EPS for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.03) by $0.01. Peregrine Pharmaceuticals had a negative return on equity of 90.82% and a negative net margin of 80.49%. The company earned $10.75 million during the quarter, compared to […]
Read more at:https://www.americanbankingnews.com/2017/03/13/peregrine-pharmaceuticals-pphm-issues-earnings-results-misses-estimates-by-0-01-eps.html

Site Created by finaceandbankingnewsnow.com